Skip to content
iStock 1341631834@2x 1

Latest News

SOMAÍ Pharmaceuticals Introduces UK to The Most Complete Cannabis-Based Product Portfolio Following a Distribution Deal
Read more

SOMAÍ Pharmaceuticals Introduces UK to The Most Complete Cannabis-Based Product Portfolio Following a Distribution Deal

SOMAÍ Pharmaceuticals Signs Distribution Deal with Grow Pharma for UK’s Most Comprehensive Range of Cannabis-Based Medicines LISBON, PORTUGAL, March 12,...
SOMAÍ Pharmaceuticals Acquires RPK Biopharma (Holigen), Reinforcing Global Leading Position in Medicinal Cannabis Sector
Read more

SOMAÍ Pharmaceuticals Acquires RPK Biopharma (Holigen), Reinforcing Global Leading Position in Medicinal Cannabis Sector

This strategic acquisition enhances SOMAÍ’s capacity with best-in-class cultivation, manufacturing, and distribution assets, making it one of the few verticals...
SOMAÍ Pharmaceuticals Introducing the U.S. Award-Winning Airo Brand to European and Australian Markets
Read more

SOMAÍ Pharmaceuticals Introducing the U.S. Award-Winning Airo Brand to European and Australian Markets

SOMAÍ Pharmaceuticals announces its partnership with AIRO BRANDS, a U.S. multi-state CPG company focused on proprietary cannabis products.   LISBON, PORTUGAL,...
SOMAÍ Pharmaceuticals and Canify Announce Their Partnership to Introduce a Cannabinoid-Based Product Line in Germany
Read more

SOMAÍ Pharmaceuticals and Canify Announce Their Partnership to Introduce a Cannabinoid-Based Product Line in Germany

SOMAÍ Pharmaceuticals and Canify AG announce their strategic partnership to introduce a differentiated cannabinoid-based product line in Germany LISBON, PORTUGAL,...
SOMAÍ Pharmaceuticals Enters German Market with Strategic Partnerships Securing €10 Million 2-year Distribution Deal
Read more

SOMAÍ Pharmaceuticals Enters German Market with Strategic Partnerships Securing €10 Million 2-year Distribution Deal

SOMAÍ Pharmaceuticals announces two significant partnerships with Canymed GmbH and Grünhorn, as part of its entry into the German market....
SOMAÍ Pharmaceuticals is thrilled to partner with the groundbreaking medical cannabis study, T21
Read more

SOMAÍ Pharmaceuticals is thrilled to partner with the groundbreaking medical cannabis study, T21

Launched in 2019 by Drug Science, and now over 4000 patients in, T21 is building the scientific evidence base for...
SOMAÍ Pharmaceuticals Signs Manufacturing Contract with Canna Forest
Read more

SOMAÍ Pharmaceuticals Signs Manufacturing Contract with Canna Forest

SOMAÍ Pharmaceuticals has signed a manufacturing agreement with Canna Forest to produce EU-GMP-certified extracted cannabis APIs and products at its...
SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million
Read more

SOMAÍ Pharmaceuticals Receives EU-GMP Certification and Raises €5 million

SOMAÍ Pharmaceuticals Unipessoal LDA, the largest European pharmaceutical cannabis product manufacturer, is pleased to announce that it has received authorisation...
SOMAÍ Pharmaceuticals has renewed the partnership with Lusófona University/CBIOS for formulation development
Read more

SOMAÍ Pharmaceuticals has renewed the partnership with Lusófona University/CBIOS for formulation development

According to this partnership, Lusófona will develop lab-scale formulations and perform corresponding stability testing. The collaboration will also encompass “In...